HPV Infection and Vaccination in Patients with Inflammatory Bowel Disease

Practical Gastroenterology

Volumn 36, Issue 10, 2012, Pages 27-31

  Gaidos, Jill K J ^a   Bickston, S J ^b  

^a Hepatology and Nutrition ^*  (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; ORAL CONTRACEPTIVE AGENT; STEROID; WART VIRUS VACCINE;

ANUS CANCER; ARTICLE; CANCER SCREENING; CROHN DISEASE; ENTERITIS; HUMAN; IMMUNE RESPONSE; INCIDENCE; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; ULCERATIVE COLITIS; UTERINE CERVIX CANCER; UTERINE CERVIX DYSPLASIA; VACCINATION;

EID: 84868219248     PISSN: 02774208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Weinstock H, Berman S, Cates W Jr. Sexually transmitted diseases among American youth; incidence and prevalence estimates, 2000. Perspect Sex Reprod Health, 2004;36:6-10.
2. Walboomers JM, Jacobs MV, Manos MM, et al. Human papilloma-virus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 1999;189(1):12-19.
3. Bosch FX, de SS. Human papillomavirus and cervical cancer -burden and assessment of causality. J Natl Cancer Inst Monogr, 2003;31:3-13.
4. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer, 2006;118:3030-3040.
5. Franco EL, Villa LL, Sobrinho JP, et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis, 1999;180:1415-1423.
6. Ho GYF, Bierman R, Beardsley L, et al. Natural history of cervico-vaginal papillomavirus infection in young women. N Engl J Med, 1998;338:423-428.
7. Centers for Disease Control and Prevention. FDA Licensure of Bivalent Human Papillomavirus Vaccine (HPV2, Cervarix) for Use in Females and Updated HPV Vaccination Recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR, 2010;59:626-629.
8. Centers for Disease Control and Prevention. FDA Licensure of QuadrivalentHuman Papillomavirus Vaccine (HPV4, Gardasil) for Use in Males and Guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR, 2010;59:630-632.
9. Bhatia J, Bratcher J, Korelitz B, et al. Abnormalities of uterine cervix in women with inflammatory bowel disease. World J Gastroenterol, 2006;12(38):6167-6171.
10. Venkatesan T, Beaulieu D, and Ferrer V. Abnormal Pap smear, cervical dysplasia and immunomodulator therapy in women with inflammatory bowel disease (IBD). Gastroenterology, 2006; 130(4):A3.
11. Huftless S, Fireman B, Kane S, et al. Screening differences and risk of cervical cancer in inflammatory bowel disease. Aliment Pharmacol Ther, 2008;28(5):598-605.
12. Kane S, Khatibi B, and Reddy D. Higher incidence of abnormal Pap smears in women with inflammatory bowel disease. Am J Gastroenterol, 2008;103:631-636.
13. Lees C, Critchley J, Chee N, et al. Cervical dysplasia and inflammatory bowel disease: no effect of disease status or immunosup-pressants on analysis of 2,199 smear records. Gastroenterology, 2008;134(4 Suppl 1):A967.
14. Singh H, Demers A, Nugent A, et al. Risk of cervical abnormalities in women with IBD: A population-based nested case-control study. Gastroenterology, 2008: 134(4 Suppl 1):A965.
15. Marehbian J, Arrighi M, Hass S, et al. Adverse events associated with common therapy regimens for moderate-to-severe Crohn's disease. Am J Gastroenterol, 2009;104:2524-2533.
16. Frisch M, Gilmelius B, van den Brule AJC, et al. Benign anal lesions, inflammatory bowel disease and risk for high-risk human papillomavirus-positive and -negative anal carcinoma. British Journal of Cancer, 1998;78(11):1534-1538.
17. Carter JJ, Koutsky LA, Hughes JP, et al. Comparison of human pap-illomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis,2000;181:1911-1919.
18. Lu Y, Ashworth L, Bousvaros A, et al. Immune response to human papillomavirus vaccine (gardisil) in girls and young women with inflammatory bowel disease. Presented at Digestive Disease Week; May 7 - 10, 2011; Chicago, Illinois. Abstract 990.
19. Long MD, Porter CQ, Sandler RS, and Kappelman MD. Suboptimal rates of cervical testing among women with infammatory bowel disease. Clin Gastroenterol Hepatol, 2009;7:549-553.
20. Selby L, Kane S, Wilson J, et al. Receipt of preventive health services by IBD patients is significantly lower than by primary care patients. Infamm Bowel Dis, 2008;14(2):253-258.
21. Machalek DA, Poynten M, Jin F, et al. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Original Text The Lancet Oncology,2012; 13(5): 487-500.